The SVP & Corp Contr of Genesis Healthcare (NYSE: GEN) is Selling Shares

By Carrie Williams

Today, the SVP & Corp Contr of Genesis Healthcare (NYSE: GEN), Stephen Scott Young, sold shares of GEN for $8,356.

In addition to Stephen Scott Young, 8 other GEN executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Currently, Genesis Healthcare has an average volume of 1.05M.

Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $3.67, reflecting a -34.6% downside. Four different firms, including Merrill Lynch and Citigroup, currently also have a Sell rating on the stock.

The insider sentiment on Genesis Healthcare has been negative according to 23 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Genesis Healthcare, Inc. is a holding company, which engages in the provision of inpatient services through skilled nursing and assisted and senior living communites. It also offers rehabilitation and respiratory therapy services. It operates through the following segments: Inpatient, Rehabilitation Therapy, and Other Services.